Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/3/2019
SIETES contiene 92692 citas

 
 
 1 a 20 de 22 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Gobbi G, Atkin T, Zytnski T, Zytynski T, Wang S, Askari S, Boruff J, Ware M, Marmorstein N, Cipriani A, Dendukuri N, Mayo N. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood. A systematic review and meta-analysis. JAMA Psychiatry 2019:13 de febrero. [Ref.ID 103030]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Furukawa TA, Maruo K, Noma H, Tanaka S, Imai H, Shinohara K, Ikeda K, Yamawaki S, Levine SZ, Goldberg Y, Leucht S, Cipriani A. Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta-analysis. Acta Psychiatr Scand 2018;137:junio. [Ref.ID 102911]
3.Enlace a cita original Cita con resumen
Cortese A, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 2018:7 de agosto. [Ref.ID 102788]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Cipriani A, Furukwa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. . Lancet 2018;391:7 de abril. [Ref.ID 102476]
5.Tiene citas relacionadas Cita con resumen
Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881-90. [Ref.ID 100612]
6. Cita con resumen
Rouse B, Cipriani A, Shi Q, Coleman AL, Dickersin K, Li T. Network meta-analysis for clinical practice guidelines: a case study, on first-line medical therapies for primary open-angle glaucoma. Ann Intern Med 2016;164:674-82. [Ref.ID 100297]
7.Tiene citas relacionadas Cita con resumen
Geddes JR, Cipriani A, Horne R. Communicating the harmful effects of medicines. BMJ 2014;348:g4047. [Ref.ID 98049]
8.Tiene citas relacionadas Cita con resumen
Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 2013;347:13. [Ref.ID 96126]
9.Tiene citas relacionadas
Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951-62. [Ref.ID 96106]
10. Cita con resumen
Cipriani A, Higgins JPT, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann Intern Med 2013;159:130-7. [Ref.ID 95865]
11. Cita con resumen
Cipriani A, Purgato M, Furukawa TA, Trespidi C, Imperadore G, Signoretti A, Churchill R, Watanabe N, Barbui C. Citalopram versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews 2012:3 de agosto. [Ref.ID 92892]
12.Tiene citas relacionadas
Barbui C, Baschirotto C, Cipriani A. EMA must improve the quality of its clinical trial reports. BMJ 2011;342:d2291. [Ref.ID 90946]
13.Tiene citas relacionadas Cita con resumen
Geddes JR, Barbui C, Cipriani A. Risk of suicidal behaviour in adults taking antidepressants. BMJ 2009;339:411-2. [Ref.ID 86541]
14.Tiene citas relacionadas Cita con resumen
Cipriani A, Geddes JR, Furukawa TA, Salanti G, Barbui C. Ranking antidepressants. Authors' reply. Lancet 2009;373:1761-2. [Ref.ID 85919]
15.Tiene citas relacionadas Cita con resumen
Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. Can Med Assoc J 2009;180:291-7. [Ref.ID 85105]
16.Enlace a cita originalTiene citas relacionadas Cita con resumen
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JPT, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373:746-58. [Ref.ID 85086]
17. Cita con resumen
Veronese A, Garatti M, Cipriani A, Barbui C. Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. Eur J Clin Pharmacol 2007;63:867-73. [Ref.ID 80977]
18.Enlace a cita originalTiene citas relacionadas Cita con resumen
Cipriani A, Geddes JR, Barbui C. Venlafaxine for major depression. BMJ 2007;334:215-6. [Ref.ID 79088]
19.Tiene citas relacionadas
Cipriani A, Furukawa TA, Churchill R, Barbui C, on behalf of the Meta-Analysis of New Generation Antidepressants (MANGA) Study group. Validity of indirect comparisons in meta-analysis. Lancet 2007;369:270-1. [Ref.ID 78978]
20.Tiene citas relacionadas
Cipriani A, Barbui C, Geddes JR. Do selective serotonin reuptake inhibitors cause suicide? Authors' reply to Raven. BMJ 2005;330:1150. [Ref.ID 73789]
Seleccionar todas
 
 1 a 20 de 22 siguiente >>